Circulating tumor DNA (ctDNA) refers to DNA fragments released from cancer cells into the bloodstream. Clinical utility of ctDNA in breast cancer has been explored in both metastatic breast cancer (MBC) and early-stage breast cancer (EBC) settings. In MBC,…
Myeloma Paper of the Day, November 24th, suggested by Robert Orlowski / cancer, Chunyan Gu, Hui Shi, Jialei Mao, Jie Min, MD Anderson Cancer Center,…
For almost five decades, the European Society for Medical Oncology (ESMO) has brought people together from all over the world to improve cancer care. However,…
The DCC is a year-round collective community movement to raise money in support of Sylvester Comprehensive Cancer Center at the University of Miami. With your…
Research reveals that Tessa Jowell’s programme not only helped early years children but went on to reduce youth crime
Click on the article title to read more.
Key PointsGerm line ERG LOF variants predispose to cytopenias and HMs.Somatic genetic rescue of ERG pathogenic variants in hematopoietic tissues impacts di
The brain senses changes to the internal state of the body, eliciting responses that maintain homeostasis. Alhadeff and Yapici provide an overview of this process,…
Stage III non–small cell lung cancer (NSCLC) is a highly heterogeneous disease with a range of treatment options that have been highlighted in the ASCO…
Introduction Pharmacist-led medication reviews are an established intervention to support patients prescribed multiple medicines or with complex medication regimes. For this systematic review, a medication…
We cover all aspects of pharmaceutical drug development; early, late phase and FDA pivotal trials; Focus on oncology, but also cover important cardiology, neurology and…
